Actos Related Clinical Trials
A Portion-Controlled Diet Will Prevent Weight Gain in Diabetics Treated With ACTOS [Active, not recruiting]
Fasting Study of Pioglitazone HCl Tablets 45 mg and Actos® Tablets 45 mg [Completed]
Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg [Completed]
A Study to Evaluate SYR-322 Plus Pioglitazone HCl (Actos®), SYR-322 Alone, or Pioglitazone HCl Alone for the Treatment of Type 2 Diabetes [Active, not recruiting]
Pioglitazone Effect on Regression of Intravascular Sonographic Coronary Obstruction Prospective Evaluation (PERISCOPE) [Completed]
Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants [Recruiting]
30 Week Parallel Group Comparison Study of Linagliptin + Pioglitazone (5+15, 5+30 and 5+45 mg) qd Versus Respective Monotherapies, Followed by 54 Week Comparison of 5mg+30mg and 5mg+45mg Versus Respective Monotherapies in Type 2 Diabetes [Recruiting]
University of Texas H.S.C. San Antonio Pioglitazone in Non-Alcoholic Steatohepatitis Trial (UTHSCSA NASH Trial) [Recruiting]
Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept [Recruiting]
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Treating Patients With Brain Tumors [Recruiting]
A Study Evaluating Triglyceride Changes in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia [Completed]
The Efficacy and Safety of Pioglitazone in Patients With Nonalcoholic Steatohepatitis [Recruiting]
Pioglitazone in Early Parkinson's Disease [Recruiting]
Pioglitazone on Pancreatic Steatosis and Bone Health [Recruiting]
Effect of Pioglitazone on Inflammation in Cystic Fibrosis [Recruiting]
Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus [Recruiting]
Pioglitazone Hydrochloride in Preventing Radiation-Induced Cognitive Dysfunction in Patients With Brain Tumors [Recruiting]
Pharmacokinetic and Biomarker Study of Pioglitazone in Adolescents With Severe Sepsis and Septic Shock [Recruiting]
Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation [Recruiting]
Effects of Pioglitazone on Igh-density Lipoprotein (HDL) Function in Persons With Diabetes [Recruiting]
The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT) [Recruiting]
Pioglitazone Incretin Study [Recruiting]
Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea [Recruiting]
Safety and Efficacy of Roflumilast and Pioglitazone in Treating Adults With Nonalcoholic SteatoHepatitis [Not yet recruiting]
Pioglitazone for the Treatment of Bipolar Disorder and Comorbid Metabolic Syndrome or Insulin Resistance [Recruiting]
Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes [Recruiting]
Combination Therapy in Amyotrophic Lateral Sclerosis (ALS) [Recruiting]
Pentoxifylline Versus Pioglitazone In Non-Alcoholic Steatohepatiti (NASH) [Recruiting]
Treating Nonalcoholic Steatohepatitis With Pioglitazone [Active, not recruiting]
Pharmacokinetic Drug Interaction Between LC15-0444 and Pioglitazone After Oral Administration in Healthy Male Subjects [Recruiting]
Pioglitazone for Oral Premalignant Lesions [Recruiting]
Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome [Recruiting]
Pilot Study of Pioglitazone for the Treatment of Moderate to Severe Asthma in Obese Asthmatics [Recruiting]
Pioglitazone Versus Placebo in Association With Pegylated Interferon and Ribavirin in Hepatitis C Virus (HCV) Patients With Insulin Resistance [Recruiting]
Chronic Pancreatitis. Effect of Pioglitazone on Endocrine Function, Exocrine Function & Structure, Pain & Life Quality [Recruiting]
Pioglitazone, Body Composition,Insulin Sensitivity and Protein Metabolism in ESRD [Recruiting]
Pilot Mouthwash Study of Pioglitazone and Simvastatin in Healthy Volunteers [Recruiting]
DPP-4 Inhibition and TZD for DM Prevention [Recruiting]
Pioglitazone for the Treatment of Insulin-Resistant and Bipolar Depression [Recruiting]
Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes [Completed]
Influence of Glitazones on the Vasodilatory Effect of High-density Lipoprotein (HDL) Lipoproteins [Recruiting]
Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin [Completed]
Effect of Pioglitazone HCl on the Microcirculation in Type 2 Diabetes Patients Treated With Insulin [Completed]
Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome Obesity [Recruiting]
Pioglitazone in Follicular or Follicular Variant of Papillary Thyroid Cancers [Recruiting]
"TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM [Completed]
A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes. [Active, not recruiting]
Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function [Recruiting]
Efficacy and Safety Study of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes. [Recruiting]
Actos Now for Prevention of Diabetes (ACT NOW) [Active, not recruiting]
The Effect of Pioglitazone on Macrovascular Outcome (Death, Heart Attack, Acute Coronary Syndrome, Heart Bypass Surgery, Stroke, Leg Bypass Surgery or Amputation) in Patients With Type 2 Diabetes [Completed]
Retreatment of Chronic Hepatitis C Non-Responders With Pegylated Interferon Alpha Plus Ribavirin Plus Pioglitazone [Suspended]
Exercise and Pioglitazone for HIV-Metabolic Syndromes [Recruiting]
Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or Insulin [Terminated]
Treatment of Nonalcoholic Steatohepatitis With Pioglitazone [Completed]
Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus. [Recruiting]
Efficacy of SYR-322 and With Pioglitazone in Patients With Type 2 Diabetes. [Recruiting]
Placebo-Controlled Study of the Combination of SYR-322 and Pioglitazone HCl in the Treatment of Type 2 Diabetes [Active, not recruiting]
The Effect of Pioglitazone on Neointima Volume and Inflammatory Markers at Eight Months After Zotarolimus-Eluting Stent Implantation in Diabetic Patients [Recruiting]
Effects of Pioglitazone on Platelet Function [Recruiting]
A Study to Evaluate SYR-322 Plus Pioglitazone HCl (ACTOS®) for the Treatment of Subjects With Inadequately Controlled Type 2 Diabetes [Recruiting]
MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus [Recruiting]
Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose. [Recruiting]
How Does the Diabetes Drug, Pioglitazone, Reduce Protein Loss in the Urine? [Recruiting]
Pioglitazone vs Vitamin E vs Placebo for Treatment of Non-Diabetic Patients With Nonalcoholic Steatohepatitis (PIVENS) [Active, not recruiting]
Pioglitazone and Losartan Provides Additional Renoprotection [Completed]
Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability [Completed]
Pioglitazone Hydrochloride (Actos(Registered Trademark)) to Treat Asthma [Recruiting]
Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes [Completed]
The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome [Completed]
Pioglitazone in Treating Patients With Newly Diagnosed Stage I or Stage II Non-Small Cell Lung Cancer Who Are Undergoing Surgery [Recruiting]
Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure. [Recruiting]
Study of Pioglitazone in Patients With Amyotrophic Lateral Sclerosis [Recruiting]
Pioglitazone Plus Peginterferon and Ribavirin to Treat HIV 1-Infected Patients With HCV Genotype 1 Infection [Recruiting]
Efficacy Study of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus. [Recruiting]
Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections [Recruiting]
Efficacy Study of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation. [Recruiting]
Comparison Between Pioglitazone and SES With type2 DM [Completed]
Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus [Recruiting]
Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome [Recruiting]
Initial Combination With Pioglitazone Study [Recruiting]
Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 Patients [Terminated]
Pioglitazone to Treat Fatty Liver in People With HIV Infection [Recruiting]
Efficacy Study of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia. [Recruiting]
Pioglitazone in Hepatitis C [Recruiting]
Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes [Completed]
Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease [Completed]
Pioglitazone Therapy in Obese Children With Insulin Resistance: A Randomized, Controlled Pilot Study [Not yet recruiting]
Effect of Pioglitazone on Intima Media Thickness, Endothelial Function, and Heart Rate Variability in Patients With Impaired Glucose Tolerance [Withdrawn]
A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance. [Recruiting]
A Study to Assess Efficacy, Safety, and Tolerability of AD-4833-536 for the Treatment of Subjects With Type 2 Diabetes and Hypertension.
Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus. [Recruiting]
Effect of Thiazolidinedione Treatment Vascular Risk Markers
Pioglitazone in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
A Placebo Controlled Safety and Efficacy Study of INT131 Besylate in Type 2 Diabetes, With an Active Comparator [Recruiting]
Safety and Efficacy of Pioglitazone as an Anti-Inflammatory for the Treatment of CF Lung Disease
Pioglitazone Treatment in Polycystic Ovary Syndrome [Active, not recruiting]
Pioglitazone Or Exercise to Treat Mild Cognitive Impairment (MCI) [Not yet recruiting]
Effect of Pioglitazone on Portal and Systemic Hemodynamics in Patients With Advanced Cirrhosis [Recruiting]
Role of Pioglitazone and Berberine in the Treatment of Non-Alcoholic Fatty Liver Disease [Recruiting]
Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes. [Recruiting]
|
